Exenatide improves cisplatin induced ovarian damage through NLRP3, Nrf-2, and TLR4 pathways

Exenatide improves cisplatin induced ovarian damage through NLRP3, Nrf-2, and TLR4 pathways

Gül O. Doğan 1, Oytun Erbaş 2

1 Department of Gynecology and Obstetrics, ??i??li Hamidiye Eftal Hospital, Istanbul, Turkey; 2 Department of Physiology, Demiro??lu Bilim University Medical School, Istanbul, Turkey

Gül O. Doğan, Oytun Erbaş

La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.

*Correspondence: Gül O. Doğan, Email not available

Abstract

Full content available in the PDF

Keywords:  Cisplatin. Exenatide. Ovarian. Toxicity.

Contents

⇄ Versión en Español
DOI: 10.24875/CIRUE.M23000810
Add to Mendeley
    Descargar PDF
    English versión
    DOI: 10.24875/CIRUE.M23000810